Arbitel-MT 25 Tablet ER
Marketer
Micro Labs Ltd
Salt Composition
Telmisartan (40mg) + Metoprolol Succinate (25mg)
Overview Arbitel-MT 25 Tablet ER
Extended-release Arbitel-MT 25mg tablets manage hypertension, reducing the risk of cardiovascular events like strokes and heart attacks. Prompt treatment enhances survival rates following heart attacks. Consistent blood levels are achieved by taking the medication with food at the same time daily, as prescribed by your physician. Continue treatment as directed; discontinuation, even with symptom absence, can worsen hypertension. Lifestyle modifications, such as regular exercise, weight management, and a balanced diet, complement the medication's efficacy. Follow your doctor's instructions carefully. Possible side effects include headache, fatigue, dizziness, low blood pressure, elevated potassium, orthostatic hypotension (potentially causing fainting), shortness of breath, nausea, vomiting, abdominal discomfort, and weakness. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from a seated position. Regular monitoring of blood pressure, blood sugar, kidney function, and electrolyte levels may be necessary. Inform your doctor about pre-existing liver or kidney conditions, or pregnancy/breastfeeding, before commencing treatment. Always disclose all other medications, particularly those for hypertension or cardiac issues.
Primary Ingredients of Arbitel-MT 25 Tablet ER
No information provided. Please provide the text you wish me to rephrase.
Uses of Arbitel-MT 25 Tablet ER
Managing Elevated Blood Pressure
Major Benefits of Arbitel-MT 25 Tablet ER:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Arbitel-MT 25 Tablet ER should be administered with a meal.
Common Side effects of Arbitel-MT 25 Tablet ER:
- Headache
- Weakness
- Dizziness
- Cold extremities
- Slow heart rate
- Increased potassium level in blood
- Decreased blood pressure
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Breathlessness
- Vomiting
- Abdominal pain
How to use Arbitel-MT 25 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Arbitel-MT 25 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this extended-release tablet with a meal.
How Arbitel-MT 25 Tablet ER works:
Arbitel-MT 25 Extended-Release tablets contain a dual-action formulation, combining telmisartan and metoprolol succinate to reduce blood pressure.
SAFETY ADVICE
AlcoholUNSAFE
Combining Arbitel-MT 25 Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Arbitel-MT 25mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Medical advice is essential.
Breast feedingSAFE IF PRESCRIBED
Extended-release Arbitel-MT 25mg tablets are likely safe for use while breastfeeding. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Arbitel-MT 25mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Arbitel-MT 25 tablets are considered safe for patients with renal impairment. No alteration of the Arbitel-MT 25 tablet dosage is necessary.
LiverCAUTION
For individuals with hepatic impairment, the extended-release Arbitel-MT 25 Tablet requires careful administration. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Arbitel-MT 25 Tablet ER :
Should you forget a dose of Arbitel-MT 25 Tablet ER, take it immediately. If, however, your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Arbitel-MT 25 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |






